Related Experiment Video
Updated: Aug 5, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Opioid, Buprenorphine, Benzodiazepine, Naloxone, and Stimulant Prescriptions Dispensed to Rhode Island Residents,
Taylor J Mello1, Staci Fischer2, Kristen St John3
1Prescription Drug Monitoring Program (PDMP) Epidemiologist, Center for Health Data and Analysis (CHDA), Rhode Island Department of Health (RIDOH).
Background:
The Rhode Island Prescription Drug Monitoring Program (RI PDMP) captures dispensation records for controlled substance prescriptions in Schedules II-V and opioid antagonists dispensed in RI or to RI residents in other states.
Methods:
This report uses RI PDMP data from January 1, 2022 to December 31, 2025 to explore trends in opioid, buprenorphine, stimulant, benzodiazepine, and naloxone prescriptions dispensed to Rhode Island residents. Buprenorphine products were limited to those approved for the treatment of opioid use disorder (OUD). For the purposes of this report, buprenorphine products approved for pain management were categorized as opioids.
Results:
During this time, the number of dispensed opioids, naloxone, and buprenorphine prescriptions for OUD decreased 6%, 28%, and 11%, respectively, while the number of individuals dispensed these prescriptions decreased 5%, 28%, and 8%. Stimulant dispensations increased 16% while the number of individuals dispensed stimulants increased 19%. Benzodiazepine dispensations remained constant, but the number of individuals dispensed a benzodiazepine prescription decreased 3%. High-risk prescribing, such as individuals dispensed an opioid prescription with a >90 MME/day, decreased by 15%.
Conclusions:
In a time of declining fatal overdoses, fewer RI residents are being dispensed high-risk opioid prescriptions, and buprenorphine for OUD, though the dispensing of stimulants has increased. Surveillance and analysis of dispensing of controlled substances should continue to include multiple agents in addition to opioids to understand evolving prescribing patterns and determine where provider education and regulatory changes can improve patient safety and public health.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Opioid Receptors: Overview
Drug Abuse and Addiction: Pharmacological Phenomena